Presenter Name Title Organization.

Slides:

Advertisements

Similar presentations

Patients’ Perspective on HTA and Off-label use David Head MBA Chief Executive RP Fighting Blindness 25th Annual EuroMeeting 4-6 March 2013 RAI, Amsterdam.

Advertisements

Data Monitoring Models and Adaptive Designs: Some Regulatory Experiences Sue-Jane Wang, Ph.D. Associate Director for Adaptive Design and Pharmacogenomics,

Presentation Title: (Times New Roman---size:40) Author’s Name: …. (Affiliation)(Times New Roman---size:22) 1-2 Dec Kish Island - Iran 4 th International.

MOTOROLA and the Stylized M Logo are registered in the US Patent & Trademark Office. All other product or service names are the property of their respective.

Type presentation name here in slide master © 2007 SDL. Company Confidential. Forward-looking information is based upon multiple assumptions and uncertainties.

Disclaimer The views and opinions expressed in the following PowerPoint slides are those of the individual presenter and should not be attributed to Drug.

Introduction to Drug Rediscovery John Lisman Attorney-at-law Lisman Legal Life sciences Insert your logo in this area then delete this text box.

How to audit the role of the vendor in the conduct of outsourced studies Kristel Van de Voorde Director Global Quality Regulatory Compliance Bristol-Myers.

Presenter Name Title Organization Twitter Handle Insert your logo here, then delete text.

Click to add Presentation Title Arial 32, 5 line max title space line 3, title space line 4, title space line 5 Presenter Title Organization Insert your.

Bayesian approach to equivalence study of medical device 1 1.

Join us on Twitter: #AU2014. Class summary text goes here Class summary.

Your group topic [SELECT ONE: Usability Analysis of miamidade.gov/ Analysis of Service Delivery] Group Member 1 Group Member 2 Group Member 3 Group Member.

Sherri de Coronado Enterprise Vocabulary Services NCI Center for Bioinformatics and Information Technology March 11, 2009 A Terminology.

Making Comments Count for High-Impact Regulations and Guidelines in the US Virginia (Ginny) Beakes-Read Executive Director, Global Regulatory Policy and.

Strategic Analyses and Interpretation: Regulatory Intelligence for Decision Making Amy N. Grant Director, Regulatory Strategy & Science ViroPharma Incorporated.

Good Laboratory Practices and Inspection Readiness Paul Swidersky President/Sr. Consultant Quality Associates, Inc.

Meredith Brown-Tuttle, RAC Director APT Pharmaceuticals, Inc.

DIA ERS SIAC IND CMC eCTD Submissions Part II – IND to NDA

Process-based Metadata From a DIA Presentation: eTMF – Migrating from Paper Trial Master Files to Electronic Eldin Rammell, Managing Director, Rammell.

Experiences from building a lessons- learned database for regulatory interactions Åsa Rembratt Sr Reg Intelligence Manager Novo Nordisk A/S 26th Annual.

Group Sequential Tests for Delayed Responses Christopher Jennison Department of Mathematical Sciences University of Bath Lisa Hampson Department of Mathematics.

Making Comments Count for High-Impact Regulations and Guidelines in Canada, EU, Japan, and US Chairperson: Amy N. Grant Director, Regulatory Strategy &

Gabor Fari Life Sciences Solution Strategist Microsoft Corporation

Session Title Date ǀ Time

- A “Portable” Implementation

Mutagenic Impurities: Guidances Update w/ CMC Perspectives

Presenter Title Organization

Track 11 Symposium 27 June :30 – 3:00 PM

Clinical Trial Disclosure:

Perspective on GCP Warning Letters

Molly Butler Auditor II Quality Associates, Inc.

Interactive Session: Presentation of Scenarios and Q&A

Presentation Title: (Times New Roman---size:40)

Community-Based and Cluster-Randomized Studies –‘Pragmatic’ Approaches for Life Cycle Evidence? Florian Eichmann, PhD Principal Scientific Affairs and.

FirstPoint and FirstDoc Application of the DIA EDM Reference Model

1 Topic Title First slide 2 line 3 line 4 line

Authors’ names and affiliations

1 Topic Title First slide 2 line 3 line 4 line

Session Title Use Font size 40

Birmingham, UK, 2nd - 5th September 2018

Main point 6 point smaller than slide title

PMI® Leadership Institute Meeting 2018―EMEA

Presentation Title Use Font size 40

Author Author’s Company

PMI® EMEA Congress 2018 Session Title Session Date | Time

Presentation Title Use Font size 40

Presenter Name Title Organization.

市场营销学武科大中南分校市场营销精品课程组.

Disclaimer The views and opinions expressed in the following PowerPoint slides are those of the individual presenter and should not be attributed to Drug.

1 Session Title 2 line 3 line 4 line

Title Chapter 22 Image Slides

Contents Click to add Title Click to add Title Click to add Title

ATTN Presenters – please review and remove this slide from your PowerPoint deck before uploading.

Authors’ names and affiliations

Session Title Date ǀ Time

Birmingham, UK, 2nd - 5th September 2018

Author Author’s Company

1 Session Title 2 line 3 line 4 line

1 Topic Title First slide 2 line 3 line 4 line

1 Topic Title First slide 2 line 3 line 4 line

Author Author’s Company

TITLE (FONT SIZE 32, BOLD, CAPITAL LETTERS)

UPEC rd International Universities Power Engineering Conference

UPEC th International Universities Power Engineering Conference

2019 Fresh and natural PPT Template

William W. Gregory for the CIOMS MLG Exploratory Team Pfizer Inc

UPEC th International Universities Power Engineering Conference

SESSION TITLE Session # <insert number here> Date Month Year

SESSION TITLE Session #<insert number here> Date Month Year

Presentation transcript:

Presenter Name Title Organization

Disclaimer The views and opinions expressed in the following PowerPoint slides are those of the individual presenter and should not be attributed to Drug Information Association, Inc. (“DIA”), its directors, officers, employees, volunteers, members, chapters, councils, Communities or affiliates, or any organization with which the presenter is employed or affiliated. For work prepared by US government employees representing their agencies, there is no copyright and these work products can be reproduced freely. Drug Information Association, Drug Information Association Inc., DIA and DIA logo are registered trademarks. All other trademarks are the property of their respective owners.

Title of Slide Content: (Create presentation information here) Minimum recommended font size of 28 Maximum recommended number of lines to be displayed per page is 8 Keep information on the screen and away from the edges. File Naming Criteria: Keep it short, no slashes or commas etc.: Smith_J_reference_v1

Thank You Presenter Name Title Organization Your Twitter Handle Join the conversation #DIA2017